0 Bedömningar
ID

14140

Beskrivning

Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01509755

Länk

https://clinicaltrials.gov/show/NCT01509755

Nyckelord

Versioner (1)
  1. 2016-03-31 2016-03-31 -
Uppladdad den

31 mars 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Eligibility Diabetes NCT01509755

    Engelsk

    Eligibility Diabetes NCT01509755

    1 Formulär  
    1. StudyEvent: Eligibility
      1. Eligibility Diabetes NCT01509755
    Inclusion Criteria
    Beskrivning

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    subjects with type 2 diabetes
    Beskrivning

    Type 2 Diabetes

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0011860
    duration of diabetes at least 3 months
    Beskrivning

    Duration of Diabtes

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0872146
    UMLS CUI [1,2]
    C0011860
    both diet treated and patients in therapy with oha (oral hypoglycemic agents)
    Beskrivning

    Diabetic diet and oral hypoglycemic agents

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0011878
    UMLS CUI [2]
    C0359086
    body mass index maximum 40 kg/m^2
    Beskrivning

    Body mass index

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C1305855
    hba1c based on analysis from central laboratory: between 7.5-10.0%, both inclusive, for diet treated, or maximum 9.0% for oha treated
    Beskrivning

    Hba1c

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0019018
    Exclusion Criteria
    Beskrivning

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    liver or renal disease
    Beskrivning

    Liver or renal disease

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0023895
    UMLS CUI [2]
    C0022658
    cardiac problems
    Beskrivning

    Cardiac problems

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0262402
    uncontrolled treated/untreated hypertension
    Beskrivning

    Hypertension

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0020538
    proliferative retinopathy
    Beskrivning

    Proliferative retinopathy

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0339467
    recurrent severe hypoglycaemia as judged by the investigator
    Beskrivning

    Recurrent severe hypoglycaemia

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0342316
    known or suspected allergy to trial product or related products
    Beskrivning

    Allergy to trial product

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C3854006
    use of any drug (except for ohas) which in the investigator's opinion could interfere with the blood glucose level
    Beskrivning

    Pharmacotherapy interferes with blood glucose level

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0013216
    UMLS CUI [1,2]
    C0521102
    UMLS CUI [1,3]
    C0392201
    Tillbaka till toppen

    Similar models

    Eligibility Diabetes NCT01509755

    1 Formulär
    1. StudyEvent: Eligibility
      1. Eligibility Diabetes NCT01509755
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Type 2 Diabetes
    Item
    subjects with type 2 diabetes
    boolean
    C0011860 (UMLS CUI [1])
    Duration of Diabtes
    Item
    duration of diabetes at least 3 months
    boolean
    C0872146 (UMLS CUI [1,1])
    C0011860 (UMLS CUI [1,2])
    Diabetic diet and oral hypoglycemic agents
    Item
    both diet treated and patients in therapy with oha (oral hypoglycemic agents)
    boolean
    C0011878 (UMLS CUI [1])
    C0359086 (UMLS CUI [2])
    Body mass index
    Item
    body mass index maximum 40 kg/m^2
    boolean
    C1305855 (UMLS CUI [1])
    Hba1c
    Item
    hba1c based on analysis from central laboratory: between 7.5-10.0%, both inclusive, for diet treated, or maximum 9.0% for oha treated
    boolean
    C0019018 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Liver or renal disease
    Item
    liver or renal disease
    boolean
    C0023895 (UMLS CUI [1])
    C0022658 (UMLS CUI [2])
    Cardiac problems
    Item
    cardiac problems
    boolean
    C0262402 (UMLS CUI [1])
    Hypertension
    Item
    uncontrolled treated/untreated hypertension
    boolean
    C0020538 (UMLS CUI [1])
    Proliferative retinopathy
    Item
    proliferative retinopathy
    boolean
    C0339467 (UMLS CUI [1])
    Recurrent severe hypoglycaemia
    Item
    recurrent severe hypoglycaemia as judged by the investigator
    boolean
    C0342316 (UMLS CUI [1])
    Allergy to trial product
    Item
    known or suspected allergy to trial product or related products
    boolean
    C0020517 (UMLS CUI [1,1])
    C3854006 (UMLS CUI [1,2])
    Pharmacotherapy interferes with blood glucose level
    Item
    use of any drug (except for ohas) which in the investigator's opinion could interfere with the blood glucose level
    boolean
    C0013216 (UMLS CUI [1,1])
    C0521102 (UMLS CUI [1,2])
    C0392201 (UMLS CUI [1,3])
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial